Semaphorin 3E Promotes Susceptibility to Leishmania major Infection in Mice by Suppressing CD4+ Th1 Cell Response
- 1 February 2021
- journal article
- research article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 206 (3), 588-598
- https://doi.org/10.4049/jimmunol.2000516
Abstract
Protective immunity to cutaneous leishmaniasis is mediated by IFN-γ–secreting CD4+ Th1 cells. IFN-γ binds to its receptor on Leishmania-infected macrophages, resulting in their activation, production of NO, and subsequent destruction of parasites. This study investigated the role of Semaphorin 3E (Sema3E) in host immunity to Leishmania major infection in mice. We observed a significant increase in Sema3E expression at the infection site at different timepoints following L. major infection. Sema3E-deficient (Sema3E knockout [KO]) mice were highly resistant to L. major infection, as evidenced by significantly (p < 0.05–0.01) reduced lesion sizes and lower parasite burdens at different times postinfection when compared with their infected wild-type counterpart mice. The enhanced resistance of Sema3E KO mice was associated with significantly (p < 0.05) increased IFN-γ production by CD4+ T cells. CD11c+ cells from Sema3E KO mice displayed increased expression of costimulatory molecules and IL-12p40 production following L. major infection and were more efficient at inducing the differentiation of Leishmania-specific CD4+ T cells to Th1 cells than their wild-type counterpart cells. Furthermore, purified CD4+ T cells from Sema3E KO mice showed increased propensity to differentiate into Th1 cells in vitro, and this was significantly inhibited by the addition of recombinant Sema3E in vitro. These findings collectively show that Sema3E is a negative regulator of protective CD4+ Th1 immunity in mice infected with L. major and suggest that its neutralization may be a potential therapeutic option for treating individuals suffering from cutaneous leishmaniasis.Keywords
Funding Information
- Canadian Institutes of Health Research (MOP 114932)
This publication has 41 references indexed in Scilit:
- Analysis of localized immune responses reveals presence of Th17 and Treg cells in cutaneous leishmaniasis due to Leishmania tropicaBMC Immunology, 2013
- Plexin-B2 and Plexin-D1 in Dendritic Cells: Expression and IL-12/IL-23p40 ProductionPLOS ONE, 2012
- The p110δ Isoform of Phosphatidylinositol 3-Kinase Controls the Quality of Secondary Anti-Leishmania Immunity by Regulating Expansion and Effector Function of Memory T Cell SubsetsPublished by The American Association of Immunologists ,2010
- IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovaniJCI Insight, 2009
- IL-17 Promotes Progression of Cutaneous Leishmaniasis in Susceptible MiceThe Journal of Immunology, 2009
- The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine developmentImmunological Reviews, 2004
- MHC Class II Expression Restricted to CD8α+ and CD11b+ Dendritic Cells Is Sufficient for Control of Leishmania major The Journal of Experimental Medicine, 2004
- CD4+CD25+ regulatory T cells control Leishmania major persistence and immunityNature, 2002
- Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice.The Journal of Experimental Medicine, 1996
- A limiting dilution assay for quantifying Leishmania major in tissues of infected miceParasite Immunology, 1985